Source link : https://www.newshealth.biz/health-news/does-finerenones-efficacy-diminish-if-initiated-late-in-heart-failure/

The benefit-risk profile of finerenone (Kerendia) for heart failure and mildly reduced or preserved ejection fraction (HFmrEF, HFpEF) was arguably unchanged with delayed initiation, according to the FINEARTS-HF trial. An analysis by time since a patient’s worsening heart failure (WHF) event showed that the efficacy of finerenone at reducing the primary composite outcome appeared best […]

Author : News Health

Publish date : 2024-09-29 19:18:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version